Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway
收藏官方服务:
资源简介:
figure 2C,2D,2E,2G;Figure 3C;cell titer glotranscriptomic analysis
创建时间:
2022-10-28

figure 2C,2D,2E,2G;Figure 3C;cell titer glotranscriptomic analysis